Studies have shown that active fund managers routinely underperform the S&P500 index*​

Coya Therapeutics, Inc. (NASDAQ: COYA)

COYA Stock Predictions and Ratings

WSX Rating:
STRONG BUY
WSX Forecast (1yr):
370.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
221.10%

COYA Stock Analysis

COYA PE Ratio:

COYA PEG Ratio: Not Available

COYA Forward EPS Growth (12 month): 0.00%

COYA PS Ratio: 10.6

COYA PSG Ratio:

COYA Forward Revenue Growth (12 month): 400.00%

COYA Articles

No data was found